已收盤 09-19 16:00:00 美东时间
+0.090
+1.30%
Rodman & Renshaw analyst Brandon Folkes reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $16 price target.
09-13 23:48
Emergent BioSolutions (NYSE:EBS) announced Friday it has agreed to pay $40M to settle a securities class action litigation pending in the U.S. District Court for the District of Maryland. The litigati...
09-13 19:14
Bavarian Nordic’s (OTCPK:BVNKF) European listed shares were down around 7% Thursday morning, the day after a published study showed that a mpox vaccine being developed by Moderna (NASDAQ:MRNA) appeare...
09-05 23:05
Shares of Emergent BioSolutions (NYSE:EBS) fell sharply on Tuesday after the Maryland-based biotech announced a new credit facility agreement with Oak Hill Advisors to secure a term loan worth up to $...
09-04 03:08
Africa-based drugmaker Aspen Pharmacare (OTCPK:APNHF) is in talks with partners to manufacture mpox vaccines as the continent grapples with a deadly outbreak attributed to a new strain of the virus, R...
09-04 01:49
Emergent Biosolutions (EBS) has issued an update. Emergent BioSolutions Inc. se...
09-03 20:20
Gainers Theriva Biologics (AMEX:TOVX) shares moved upwards by 34.2% to $6.31 d...
09-02 20:05
A Philadelphia judge's early ruling in the Ozempic and Wegovy litigation may shape the outcome of the lawsuits against Novo Nordisk and Eli Lilly, focusing on the diagnosis of gastroparesis and the adequacy of drug warnings.
08-31 01:38